Recent Court of Justice of the European Union (CJEU) judgements on the interpretation of supplementary protection certificate (SPC) regulations are not clear and have left judges frustrated, said Huw Evans, a partner at Norton Rose LLP, speaking at the 1st Annual Life Sciences Law Forum in London.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email James Lynn on email@example.com.
SPC, CJEU, IPO